Inventor · disambiguated record
David T. Macpherson
Also filed as: MACPHERSON DAVID · MACPHERSON DAVID T · MACPHERSON DAVID TIMOTHY
19 granted patents·9 pending applications·189 citations·filing 1989–2021
94Inventor score
Files withCONVERGENCE PHARMACEUTICALS11GLAXO GROUP LTD5SMITHKLINE BEECHAM PLC4BEECHAM GROUP PLC3BIOGEN INC3
Top patents by PatentIndex Score
28 records- 0193US7253198B2Hydroxyethylamine derivatives for the treatment of Alzheimer's diseaseGLAXO GROUP LTD·Filed 2003·Granted Aug 7, 2007·70 cites·16 claims
- 0292US7960563B2Indazoles used to treat estrogen receptor beta mediated disordersGLAXO GROUP LTD·Filed 2008·Granted Jun 14, 2011·33 cites·3 claims
- 0385US9737536B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Granted Aug 22, 2017·3 cites·13 claims
- 0485US6992103B2Benzamide derivatives, processes for their preparation, and their pharmaceutical useSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 31, 2006·30 cites·25 claims
- 0584US9376445B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Jun 28, 2016·4 cites·11 claims
- 0683US10010551B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2017·Granted Jul 3, 2018·2 cites·10 claims
- 0783US9309254B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Apr 12, 2016·4 cites·24 claims
- 0879US10485801B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2018·Granted Nov 26, 2019·1 cites·14 claims
- 0972US2020289508A1Novel pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1070US2022033408A1Process for preparing spiro derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1167US10421716B2Process for preparing alpha-carboxamide pyrrolidine derivativesCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Sep 24, 2019·1 cites·26 claims
- 1267US9376436B22-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorsCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Jun 28, 2016·1 cites·12 claims
- 1367US5204330AAntifungal compoundsBEECHAM GROUP PLC·Filed 1990·Granted Apr 20, 1993·25 cites·7 claims
- 1463US11149039B2Process for preparing spiro derivativesBIOGEN INC·Filed 2018·Granted Oct 19, 2021·0 cites·19 claims
- 1559US9303032B22-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Apr 5, 2016·0 cites·7 claims
- 1659US5066646AAmphotericin derivativesBEECHAM GROUP PLC·Filed 1989·Granted Nov 19, 1991·10 cites·7 claims
- 1759US2016184306A1Novel Pyrimidinyl-DiazoSpiro CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 1851US8536182B2Benzylpiperazine derivatives and their medical useJOHNSON CHRISTOPHER NORBERT·Filed 2006·Granted Sep 17, 2013·0 cites·16 claims
- 1951US7956083B2CompoundsGLAXO GROUP LTD·Filed 2009·Granted Jun 7, 2011·0 cites·3 claims
- 2051US2013317041A1CompoundsGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 2150US2004209822A1Novel compoundsSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 2249US2016185758A12-(Pyridin-2-yl)-1, 7-Diaza-Spiro [4.4] Nonane-6-One Compound as Voltage-Gated Sodium Channel ModulatorCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 2346US2008058391A1Novel compoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2441US5116960AAmphotericin b derivativesBEECHAM GROUP PLC·Filed 1989·Granted May 26, 1992·3 cites·9 claims
- 2541US2020255438A1Novel saltsBIOGEN INC·Filed 2018·Application pending·0 cites
- 2641US2003207923A12,'3-Amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitorsFiled 2000·Application pending·0 cites
- 2730US6458779B1Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF releaseSMITHKLINE BEECHAM PLC·Filed 1999·Granted Oct 1, 2002·2 cites·13 claims
- 2830US6147111APhenyl derivatives useful as endothelin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 1999·Granted Nov 14, 2000·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →